Evidence map›Paper›PMID 34704090›Full record

ArticleResearch square2021

Severe Acute Respiratory Syndrome Coronavirus-2 Seropositivity in South-Central Uganda, During 2019 - 2021.

Charles Ssuuna, Ronald Moses Galiwango, Edward Nelson Kankaka, Joseph Kagaayi, Anthony Ndyanabo, Godfrey Kigozi, Gertrude Nakigozi, Tom Lutalo, Robert Ssekubugu, John Bosco Wasswa and 16 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 2 countries.

Charles SsuunaRakai Health Sciences Program.
Ronald Moses GaliwangoRakai Health Sciences Program.
Edward Nelson KankakaRakai Health Sciences Program.
Joseph KagaayiMakerere University School of Public Health.
Anthony NdyanaboRakai Health Sciences Program.
Godfrey KigoziRakai Health Sciences Program.
Gertrude NakigoziRakai Health Sciences Program.
Tom LutaloUganda Virus Research Institute.
Robert SsekubuguRakai Health Sciences Program.
John Bosco WasswaRakai Health Sciences Program.
Anthony MayinjaRakai Health Sciences Program.
Martina Cathy NakibuukaRakai Health Sciences Program.
Samiri JamiruRakai Health Sciences Program.
John Baptist OketchRakai Health Sciences Program.
Edward MuwangaKyotera District Health Office, Ministry of Health.
Larry William ChangDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Mary Kate GrabowskiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Maria WawerDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Ronald GrayDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Mark AndersonAbbott Laboratories, Abbott Diagnostics Division, Abbott Park, Illinois.
Michael StecAbbott Laboratories, Abbott Diagnostics Division, Abbott Park, Illinois.
Gavin ClohertyAbbott Laboratories, Abbott Diagnostics Division, Abbott Park, Illinois.
Oliver LaeyendeckerDivision of Infectious Disease, Division of Medicine, Johns Hopkins School of Medicine, Baltimore, MD.
Steven James ReynoldsDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Thomas C QuinnDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
David SerwaddaMakerere University School of Public Health.
Rakai Health Sciences Program · UGNational Institutes of Health · USJohns Hopkins University · USMakerere University · UGUganda Virus Research Institute · UG

Funding

Multidisciplinary Research Training to Understand and Reduce HIV Incidence in UgandaD43TW010557 · FIC · JOHNS HOPKINS UNIVERSITY · PI CHANG, LARRY WILLIAM · 2018 to 2022
$1.6M
FIC NIH HHS D43 TW010557
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34704090
PMCPMC8547523
OpenAlexW3208192855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.